VA
SUPN icon

Vident Advisory’s Supernus Pharmaceuticals SUPN Stock Holding History

Vident Advisory’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,467
Closed -$596K – 1736
2025
Q3 		$596K Sell
12,467
-1,783
-13% -$71.8K 0.01% 1104
2025
Q2 		$449K Sell
14,250
-636
-4% -$20.4K 0.01% 1121
2025
Q1 		$488K Buy
14,886
+494
+3% +$17.5K 0.01% 1044
2024
Q4 		$520K Buy
14,392
+309
+2% +$10.9K 0.01% 919
2024
Q3 		$439K Sell
14,083
-8,793
-38% -$274K 0.01% 1001
2024
Q2 		$612K Buy
22,876
+7,713
+51% +$224K 0.02% 789
2024
Q1 		$517K Buy
15,163
+1,332
+10% +$39.7K 0.01% 810
2023
Q4 		$400K Buy
13,831
+2,879
+26% +$76.3K 0.01% 880
2023
Q3 		$302K Buy
+10,952
New +$333K 0.01% 900

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return